Position in NPCE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,916,436
-$3,652,894 QoQ
Shares Held
1,505,125
-28.2% QoQ
Ownership
4.39%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#6
of 112 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $218,961,143 across 6 Medical Devices names. NPCE ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
834,900 | $75,525,054 | |
| 2 | BSX |
Boston Scientific Corp
|
1,483,200 | $63,302,976 | |
| 3 | SYK |
Stryker Corp
|
159,100 | $50,091,044 | |
| 4 | NPCE |
NeuroPace Inc
This page
|
1,505,125 | $23,916,436 | |
| 5 | AORT |
Artivion, Inc.
|
175,000 | $3,932,250 | |
| 6 | NSPR |
InspireMD, Inc.
|
3,133,405 | $2,193,383 |
All Filings in NPCE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,916,436 | 1,505,125 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $23,916,436 | 1,505,125 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,569,330 | 2,096,527 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $27,569,330 | 2,096,527 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,153,812 | 2,406,335 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,952,237 | 2,614,184 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,122,009 | 2,614,184 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $29,122,009 | 2,614,184 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,863,857 | 3,406,335 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $41,863,857 | 3,406,335 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,116,888 | 3,406,335 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,742,154 | 3,406,335 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,751,892 | 3,406,335 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $52,852,364 | 4,003,967 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $41,280,899 | 4,003,967 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,039,494 | 4,012,281 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,015,141 | 4,012,281 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,616,983 | 4,012,281 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,978,298 | 4,012,281 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,046,053 | 4,012,281 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,860,790 | 4,012,281 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $32,940,827 | 4,012,281 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,443,792 | 4,012,281 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,594,653 | 4,012,281 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $95,452,164 | 4,012,281 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||